EC Number   |
Disease |
PubMed ID |
Title of Publication |
Category |
Confidence Level |
|---|
   3.5.1.28 | Bacterial Infections |
7801634 |
[Cloning of T7 lysozyme gene and construction of the vector for transgenic plants resistant to bacterial infection] |
therapeutic application
unassigned |
1
0 |
| 3.5.1.28 | Bacterial Infections |
16714290 |
Differential expression of peptidoglycan recognition protein 2 in the skin and liver requires different transcription factors. |
therapeutic application
unassigned |
1
0 |
| 3.5.1.28 | Bacterial Infections |
25038926 |
Biochemical and biophysical characterization of PlyGRCS, a bacteriophage endolysin active against methicillin-resistant Staphylococcus aureus. |
causal interaction
therapeutic application
unassigned |
3
4
0 |
| 3.5.1.28 | Carcinoma, Hepatocellular |
31479523 |
Tumor-Derived PGLYRP2 Predicts Survival and Antitumor Immune Responses in Hepatocellular Carcinoma. |
causal interaction
diagnostic usage
therapeutic application
unassigned |
3
1
2
0 |
| 3.5.1.28 | Cardiovascular Diseases |
34461924 |
PGLYRP2 as a novel biomarker for the activity and lipid metabolism of systemic lupus erythematosus. |
diagnostic usage
therapeutic application
unassigned |
2
1
0 |
| 3.5.1.28 | Cholera |
30782657 |
Endopeptidase Regulation as a Novel Function of the Zur-Dependent Zinc Starvation Response. |
causal interaction
unassigned |
2
0 |
| 3.5.1.28 | Colitis |
22615249 |
Role of mouse peptidoglycan recognition protein PGLYRP2 in the innate immune response to Salmonella enterica serovar Typhimurium infection in vivo. |
causal interaction
unassigned |
1
0 |
| 3.5.1.28 | Colitis |
25114103 |
Peptidoglycan recognition protein 3 and Nod2 synergistically protect mice from dextran sodium sulfate-induced colitis. |
unassigned |
0 |
| 3.5.1.28 | Colorectal Neoplasms |
33540681 |
CLytA-DAAO Chimeric Enzyme Bound to Magnetic Nanoparticles. A New Therapeutical Approach for Cancer Patients? |
diagnostic usage
unassigned |
1
0 |
| 3.5.1.28 | Dyslipidemias |
34461924 |
PGLYRP2 as a novel biomarker for the activity and lipid metabolism of systemic lupus erythematosus. |
diagnostic usage
therapeutic application
unassigned |
2
1
0 |
